Literature DB >> 22554361

A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study.

Mehmet Polatlı1, Cahit Bilgin, Bengü Şaylan, Şeyma Başlılar, Evren Toprak, Hasan Ergen, Nur Dilek Bakan, Levent Kart, Zennur Kılıç, Azize Üstünel, Ahmet Şengün, Yelda Varol, Adem Yılmaz, Çağatay Ataol, Didem Bulgur, Serap Bozdoğan, İlknur Tunaboyu, Zehra Gülcihan Özkan, Ekrem Uysal, Sevtap Gülgösteren, Neşe Akın, Yavuz Selim, Mustafa Irmak, Erhan Turgut, Olgun Keskin, Hilal Bektaş Uysal, Nevin Sofuoğlu, Mehmet Yılmaz.   

Abstract

INTRODUCTION: This study was designed to identify the impact of chronic obstructive pulmonary disease (COPD) on activities of daily living, life styles and needs in patients. PATIENTS AND METHODS: Participants of this national, multi-centered, cross-sectional observational study included 497 stable COPD patients from 41 centers. The mean age (standard deviation; SD) was 63.3 (9.3) years with 59.0% of the patients under the age of 65, and 89.9% of the participants were male. Sociodemographic and COPD-related data were gathered at enrollment and during the 1-month telephone follow-up.
RESULTS: The mean (SD) COPD duration was 7.3 (6.5) years in the overall population while 5.4 (4.6) years for patients who recieved COPD diagnosis at least one year after the onset of symptoms. Dyspnea was the most common (83.1%) symptom and walking up stairs (66.6%) was the most difficult activity to be performed. Majority of the patients were aware of COPD as a chronic disease (63.4%), requiring ongoing treatment (79.7%), mainly caused by smoking (63.5%). 59% of the patients were under the age of 65 years-old. In 84% of patients, graduation from at least a primary school was identified. Results revealed an average number of two dependants that were obliged to look after per patient, ability to go on an outing in 91% of the patients, and going grocery shopping with ease in more than two-thirds of the study population. There was no significant difference in regular use of medication device across different educational or age groups. The top three COPD treatment expectations of the patients were being able to breathe (24.1%), walking (17.1%), and walking up stairs (11.7%), while shortness of breath (43.3%) was the first priority treatment need.
CONCLUSION: In contrast to the common view that COPD prevalance is higher in old age population, this study showed that the rate of the disease is higher among younger patients than expected; indispensability of out of the house activities in majority of patients; and use of regular medication device to be independent of educational level and the age of COPD patients. Our findings indicate that the likelihood of COPD patient population to be composed of younger and active individuals who do not spend majority of their time at home/in bed as opposed to popular belief. Therefore, availability of a portable and easy to use device for medication seems to be important to enhance daily living.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554361     DOI: 10.5578/tt.3414

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  4 in total

1.  Therapeutic paralysis in veterans with COPD.

Authors:  Aaron M Mulhall; Laura A Lach; Sara M Krzywkowski-Mohn; Jeffrey A Welge; Ralph J Panos
Journal:  Respir Med       Date:  2013-07-01       Impact factor: 3.415

Review 2.  Use of time in people with chronic obstructive pulmonary disease--a systematic review.

Authors:  Toby Hunt; Sarah Madigan; Marie T Williams; Tim S Olds
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-12-12

3.  Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.

Authors:  Marc Beaumont; Francis Couturaud; Florence Jego; Romain Pichon; Catherine Le Ber; Loïc Péran; Christophe Rogé; David Renault; Swathi Narayan; Gregory Reychler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-30

4.  Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial.

Authors:  François Maltais; Denis E O'Donnell; Alan Hamilton; Yihua Zhao; Richard Casaburi
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.